|
POLDIP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.684100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.176900E-04 |
| Normal-vs-Stage2 |
8.043900E-03 |
| Normal-vs-Stage3 |
1.855620E-03 |
| Normal-vs-Stage4 |
8.030300E-04 |
| Stage1-vs-Stage2 |
5.586599999996E-05 |
| Stage1-vs-Stage3 |
8.881000E-01 |
| Stage1-vs-Stage4 |
4.331000E-01 |
| Stage2-vs-Stage3 |
6.00920000000116E-05 |
| Stage2-vs-Stage4 |
2.2569999999944E-05 |
| Stage3-vs-Stage4 |
5.128400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.835000E-04 |
| Normal-vs-AfricanAmerican |
2.068000E-01 |
| Normal-vs-Asian |
7.390000E-04 |
| Caucasian-vs-AfricanAmerican |
6.110200E-01 |
| Caucasian-vs-Asian |
3.227000E-01 |
| AfricanAmerican-vs-Asian |
2.578600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.193700E-02 |
| Normal-vs-Female |
1.115980E-02 |
| Male-vs-Female |
7.967600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.614140E-04 |
| Normal-vs-Age(41-60Yrs) |
7.400900E-03 |
| Normal-vs-Age(61-80Yrs) |
6.570400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.716800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.611000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.038600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.776150E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.225960E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.010600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.471400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.298420E-01 |
| Classical-VS-Follicular |
1.85109999550903E-08 |
| Classical-VS-Other |
5.057800E-01 |
| Classical-VS-Normal |
2.39539999999927E-05 |
| Tall-VS-Follicular |
1.6687999870868E-09 |
| Tall-VS-Other |
8.170200E-01 |
| Tall-VS-Normal |
1.43819999998129E-06 |
| Follicular-VS-Other |
2.564300E-02 |
| Follicular-VS-Normal |
8.058500E-03 |
| Other-VS-Normal |
1.005850E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.894000E-01 |
| Normal-vs-N1 |
5.15650000032508E-07 |
| N0-vs-N1 |
1.64840000005384E-06 |
|
|
